Robert Knoerl1, Debra L Barton2, Janean E Holden3, John C Krauss4, Beth LaVasseur5, Ellen M L Smith6. 1. Post-Doctoral Research Fellow, Phyllis F. Cantor, Center for Research in Nursing and Patient Care Services, Dana-Farber Cancer, Institute, 450 Brookline Avenue, LW 517, Boston, MA 02215, Email: Robert_knoerl@DFCI.Harvard.edu. 2. Mary Lou Willard French Professor of Nursing, University of Michigan School of Nursing, Ann Arbor, MI, Email: debbartn@umich.edu. 3. Barbara A. Therrien Collegiate Professor of Nursing, University of Michigan School of Nursing, Ann Arbor, MI, Email: holdenje@umich.edu. 4. Assistant Professor, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, Email: jkrauss@med.umich.edu. 5. Director of Oncology Research and Operation, St. Joseph Mercy Hospital, Ann Arbor, MI, Email: beth.lavasseur@st.joeshealth.org. 6. Associate Professor, University of Michigan School of Nursing, Ann Arbor, MI, Email: ellenls@umich.edu.
Abstract
PURPOSE: Preliminary evidence suggests that a self-guided cognitive and behaviourally-based pain management intervention (PROSPECT) is effective for chronic painful chemotherapy-induced peripheral neuropathy (CIPN), but its mechanism of action is unknown. The purpose of this secondary analysis was to explore if changes in anxiety, depression, sleep-related impairment, or fatigue mediated improvements in worst pain following PROSPECT in individuals with chronic painful CIPN. METHODS: Sixty participants were randomized to receive self-guided cognitive behavioural pain management (access for eight weeks) or treatment as usual. A seven-day worst CIPN pain diary and the PROMIS measures of anxiety, depression, fatigue, and sleep-related impairment were administered pre/posttest (eight-weeks). Causal mediation analysis was used to quantify mediators of worst pain improvement. RESULTS: None of the hypothesized mediators had a statistically significant effect on worst pain (n=38). IMPLICATIONS: Further research is needed to identify potential mediators of pain intensity that can be targeted by specific cognitive behavioural strategies to improve painful CIPN severity.
PURPOSE: Preliminary evidence suggests that a self-guided cognitive and behaviourally-based pain management intervention (PROSPECT) is effective for chronic painful chemotherapy-induced peripheral neuropathy (CIPN), but its mechanism of action is unknown. The purpose of this secondary analysis was to explore if changes in anxiety, depression, sleep-related impairment, or fatigue mediated improvements in worst pain following PROSPECT in individuals with chronic painful CIPN. METHODS: Sixty participants were randomized to receive self-guided cognitive behavioural pain management (access for eight weeks) or treatment as usual. A seven-day worst CIPN pain diary and the PROMIS measures of anxiety, depression, fatigue, and sleep-related impairment were administered pre/posttest (eight-weeks). Causal mediation analysis was used to quantify mediators of worst pain improvement. RESULTS: None of the hypothesized mediators had a statistically significant effect on worst pain (n=38). IMPLICATIONS: Further research is needed to identify potential mediators of pain intensity that can be targeted by specific cognitive behavioural strategies to improve painful CIPN severity.
Authors: Ruth McCorkle; Elizabeth Ercolano; Mark Lazenby; Dena Schulman-Green; Lynne S Schilling; Kate Lorig; Edward H Wagner Journal: CA Cancer J Clin Date: 2011-01-04 Impact factor: 508.702
Authors: Anna-Liisa Kautio; Maija Haanpää; Hannu Kautiainen; Eija Kalso; Tiina Saarto Journal: Support Care Cancer Date: 2010-11-16 Impact factor: 3.603
Authors: Lan Yu; Daniel J Buysse; Anne Germain; Douglas E Moul; Angela Stover; Nathan E Dodds; Kelly L Johnston; Paul A Pilkonis Journal: Behav Sleep Med Date: 2011-12-28 Impact factor: 2.964
Authors: David Cella; Susan Yount; Nan Rothrock; Richard Gershon; Karon Cook; Bryce Reeve; Deborah Ader; James F Fries; Bonnie Bruce; Mattias Rose Journal: Med Care Date: 2007-05 Impact factor: 2.983